Core Viewpoint - The company,拓新药业, has received a laboratory accreditation certificate from the China National Accreditation Service for Conformity Assessment (CNAS) for its subsidiary, 河南省核苷药物研究院有限公司, which signifies national and international recognition of its management and technical capabilities [1] Group 1 - The accreditation enhances the company's ability to conduct testing according to national standards, which is crucial for ensuring product quality [1] - This recognition is expected to strengthen the company's product development capabilities and increase customer trust and recognition [1] - The overall impact of this accreditation is anticipated to improve the company's competitive edge and promote sustainable high-quality development [1]
拓新药业(301089.SZ)：子公司获得中国合格评定国家认可委员会实验室认可证书